AMERISAFE (NASDAQ:AMSF) Stock

AMERISAFE

AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.

Earnings

News

Dividends

Price Target

Buybacks

Small Cap

Markets

Analyst Ratings

Trading Ideas

Insurance

AMSF

AMERISAFE, Inc. (NASDAQ: AMSF) is currently considered expensive on a relative basis, with the stock trading at a 22X forward 12-month price-to-earnings (P/E) ratio, which is at a premium compared with its five-year median of 20.21X and the Zacks Insurance - Accident and Health average of 13.36X.

Is AMERISAFE Stock a Pricey Pick or a Hidden Gem for Your Portfolio?

Earnings Misses

KNSL

AMERISAFE, Inc.&#39;s (NASDAQ: AMSF) shares have lost 5.3% since it reported second-quarter 2024 results on Jul 29. Investors may have been worried about weakness in underwriting results inducing a deterioration in the net combined ratio.

AMERISAFE Stock Down 5.3% Since Q2 Earnings Miss

Penny Stocks

Short Ideas

Pre-Market Outlook

CTLP

LMND

OPRT

The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies.

Top 5 Financial Stocks That Could Sink Your Portfolio This Quarter

AMERISAFE Inc

Truist Securities analyst Mark Hughes maintains AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) with a Hold and raises the price target from $48 to $54.

Truist Securities Maintains Hold on AMERISAFE, Raises Price Target to $54

WIIM

Amerisafe shares are trading higher after the company reporting better-than-expected Q3 financial results. The company also announced a special dividend of $3.00 per share.

AMERISAFE Declares Special Dividend Of $3.00 Per Share

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.58 by 29.31 percent. The company reported quarterly sales of $78.695 million which beat the analyst consensus estimate of $75.320 million by 4.48 percent. This is a 8.34 percent increase over sales of $72.640 million the same period last year.

Earnings Beats

AMERISAFE Q3 2024 Adj. EPS $0.75 Beats $0.58 Estimate, Sales $78.695M Beat $75.320M Estimate

JMP Securities analyst Matthew Carletti reiterates AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) with a Market Outperform and maintains $65 price target.

Reiteration

JMP Securities Reiterates Market Outperform on AMERISAFE, Maintains $65 Price Target

AMERISAFE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsf#NASDAQ">AMSF</a>) is currently considered expensive on a relative basis, with the stock trading at a 22X forward 12-month price-to-earnings (P/E) ratio, which is at a premium compared with its five-year median of 20.21X and the Zacks&nbsp;Insurance - Accident and Health average of 13.36X. A premium valuation generally indicates that the market has strong confidence in the company&#39;s prospects. However, this necessitates scrutiny to determine if this higher price is warranted.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/a5/80818.jpg?v=1155545738" style="border-style:solid; border-width:1px; height:310px; width:600px" />
Image Source: Zacks Investment Research
In comparison, other insurers like&nbsp;Employers Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eig#NYSE">EIG</a>) and&nbsp;ProAssurance Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>) are cheaper at 13.30X and 19.72X, respectively.
A brief analysis is needed to determine whether AMSF&#39;s premium valuation is justified based on its growth prospects and fundamentals.
Let&#39;s delve deeper.
Incorporated in 1985 and headquartered in DeRidder, LA, AMERISAFE currently has a market cap of $909.9 million. It is well positioned for growth, leveraging rising investment income and a robust balance sheet.
AMSF&#39;s extensive experience in hazardous industries and a high policy retention rate are major positives. Its cost-saving initiatives are expected to support its bottom line. Last year, it lowered loss and loss adjustment expenses by 2.7%.
The long time lag between receiving premiums and settling claims allows the company to invest funds for extended periods, compounding returns more effectively than insurers with quicker claim payouts, thereby boosting its investment income potential. Last year, it recorded a net investment income of $31.3 million, which advanced by 15.1%, resulting from increased fixed-income reinvestment rates. The first half of 2024 also witnessed higher reinvestment rates.
AMSF&#39;s solid balance sheet, with no debt and $884.2 million in investments and cash as of June 30, 2024, supports initiatives to boost shareholder value. The company raised its quarterly dividend by 8.8% in February 2024, continuing its steady dividend payments since 2013. In the second quarter, AMERISAFE repurchased $4.1 million worth of shares, with $6.3 million remaining in its buyback program as of June 30.
<h2>Should Investors Pay the Premium for AMSF?</h2>
The factors mentioned above have contributed to AMERISAFE&#39;s premium valuation, reflecting strong investor confidence in its future growth and profitability. As a result, investors are willing to pay a higher price for the stock, anticipating that it will outperform both its industry peers and the broader market in the coming months.
However, uncertainty surrounds the stock due to AMERISAFE&#39;s continuous decline in net premiums earned over the past five years. If this trend persists, it could potentially impede the company&#39;s ability to enhance its profits. The Zacks Consensus Estimate for 2024 earnings is pegged at $2.40 per share, indicating a 17.5% year-over-year decline. The same for 2025 signals a further 12.5% fall.
Also, AMERISAFE has faced a downward trend in free cash flow from 2018 to 2022, indicating potential operational challenges. While it saw a 12.2% increase in 2023, the sustainability of this growth is uncertain. In the trailing 12 months, free cash flow dropped sharply by 56.7%, raising concerns about the company&#39;s long-term financial health.
Despite these headwinds, the company&#39;s overall outlook remains positive. Leading brokers have raised AMSF&#39;s short-term price target by 12.47% from its recent closing price of $47.72, with the highest target set at $65, representing a potential upside of 36.21%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/06/80819.jpg?v=1182891382" style="border-style:solid; border-width:1px; height:315px; width:600px" />
Image Source: Zacks Investment Research
Existing investors should hold onto AMERISAFE stock to capitalize on its upward price movement. However, new investors might want to wait for a better entry point. Currently, the stock has a Zacks Rank #3 (Hold) and appears overvalued, suggesting that it may not be the ideal time to buy. Waiting for a more attractive valuation could present a better opportunity to invest.
<a href="https://www.zacks.com/stock/news/2347764/is-amerisafe-stock-a-pricey-pick-or-a-hidden-gem-for-your-portfolio?cid=CS-BENZ-FT-analyst_blog|rank_focused-2347764">To read this article on Zacks.com click here.</a>

AMERISAFE, Inc.&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsf#NASDAQ">AMSF</a>) shares have lost 5.3% since it reported second-quarter 2024 results on Jul 29. Investors may have been worried about weakness in underwriting results inducing a deterioration in the net combined ratio. An elevated operating expense level, resulting from an increase in loss and loss adjustment expenses incurred, underwriting and other operating costs and policyholder dividends, also contributed to the downside. Improved audit premiums partially offset the negatives.
AMSF reported second-quarter adjusted earnings per share of 58 cents, which missed the Zacks Consensus Estimate by 4.9%. Moreover, the bottom line dipped 20.5% year over year.
Operating revenues improved 3.4% year over year to $76 million. The top line beat the consensus mark by 2.4%.
<div class="chart_embed">
<h3>AMERISAFE, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="AMERISAFE, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/32/1722871229.png" style="height:265px; width:620px" title="" />
AMERISAFE, Inc. price-consensus-eps-surprise-chart | AMERISAFE, Inc. Quote
</div>
<h3>Q2 Performance</h3>
Net premiums earned of $68.6 million improved 4.6% year over year in the quarter under review and outpaced the Zacks Consensus Estimate of $66 million. The metric benefited from improved contributions from payroll audits and related premium adjustments as a result of persistent payroll strength.
Net investment income dipped 3.6% year over year to $7.4 million due to a reduced portfolio size. However, this was partially offset by improved reinvestment rates. The metric fell short of the consensus mark of $7.8 million. Fee and other losses were $75 million.
AMERISAFE reported a pre-tax underwriting profit of $6.5 million, which declined 31.2% year over year.
Total expenses escalated 10.7% year over year to $62.1 million in the second quarter.
Operating net income of $11.1 million decreased 20.2% year over year.
The net combined ratio deteriorated 510 basis points (bps) year over year to 90.5% and came higher than the consensus mark of 90%. The metric suffered due to a deteriorating net loss ratio.
<h3>Financial Update (as of Jun 30, 2024)</h3>
AMERISAFE exited the second quarter with cash and cash equivalents of $30.6 million, which declined 20.9% from the 2023-end level.
Total assets of $1.2 billion increased 0.4% from the figure in 2023-end.
Shareholders&#39; equity of $301 million grew 2.9% from the 2023-end level.
Book value per share was $15.78 as of Jun 30, 2024, which improved 3.3% from the 2023-end figure.
Return on average equity deteriorated 400 bps year over year to 14.6% in the quarter under review.
<h3>Dividend Update</h3>
Management announced a quarterly cash dividend of 37 cents per share, which will be paid out on Sep 20, 2024, to its shareholders of record as of Sep 6.
<h3>Zacks Rank</h3>
AMERISAFE currently carries a Zacks Rank #4 (Sell).
<h3>Performances of Other Insurers</h3>
Of the insurance industry players that have reported second-quarter 2024 results so far, the bottom-line results of&nbsp;Marsh &amp; McLennan Companies, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>),&nbsp;Brown &amp; Brown, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Kinsale Capital Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knsl#NYSE">KNSL</a>) beat the Zacks Consensus Estimate.
Marsh &amp; McLennan reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year.&nbsp; Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.&nbsp; The top line, however, fell short of the consensus mark by 1%. MMC&#39;s adjusted operating income was $1.72 billion, which grew 11% year over year. Adjusted operating margin improved 130 bps year over year to 29%.
The Risk and Insurance Services segment&#39;s revenues were $4.02 billion, which advanced 8% year over year and 7% on an underlying basis. Adjusted operating income advanced 12% year over year to $1.34 billion. Revenues of Marsh, a unit within the segment, improved 8% year over year and 7% on an underlying basis to $3.27 billion. In the United States/Canada, underlying revenues grew 6% year over year. International operations also witnessed underlying revenue growth of 7%. &nbsp;
Brown &amp; Brown&#39;s second-quarter adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the consensus estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion.&nbsp;
Organic revenues improved 10% to $1 billion. Investment income more than doubled year over year to $22 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%.&nbsp;
Kinsale Capital delivered second-quarter net operating earnings of $3.75 per share, which outpaced the Zacks Consensus Estimate by 6.5%. The bottom line increased 30.4% year over year.&nbsp; Operating revenues jumped 45.1% year over year to $378 million. Revenues beat the consensus estimate of $377 million. Gross written premiums of $529.8 million rose 20.9% year over year. Net written premiums climbed 17.9% year over year to $430.2 million.&nbsp;
Net investment income increased 48.3% year over year to $35.8 million. Kinsale Capital&#39;s underwriting income was $76.1 million, which grew 23.6% year over year. The combined ratio deteriorated 100 bps to 77.7% in the quarter under review. The expense ratio deteriorated 10 bps to 21.1, while the loss ratio deteriorated 60 bps to 56.6.
<a href="https://www.zacks.com/stock/news/2316354/amerisafe-amsf-stock-down-5-3-since-q2-earnings-miss?cid=CS-BENZ-FT-analyst_blog|earnings_article-2316354">To read this article on Zacks.com click here.</a>

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.63 by 9.52 percent. This is a 21.92 percent decrease over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $75.83 million which beat the analyst consensus estimate of $74.19 million by 2.20 percent. This is a 0.23 percent increase over sales of $75.66 million the same period last year.

AMERISAFE Q2 Adj $0.57 Misses $0.63 Estimate, Sales $75.83M Beat $74.19M Estimate

AMERISAFE shares are trading lower after the company reported Q1 financial results.

AMERISAFE Q1 Operating Income Per Share $0.69

AMERISAFE Increases Quarterly Dividend From $0.34 To $0.37/Share

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
AMERISAFE beat estimated earnings by 4.23%, reporting an EPS of $0.74 versus an estimate of $0.71.
Revenue was up $355 thousand from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.08 which was followed by a 2.77% drop in the share price the next day.
Here's a look at AMERISAFE's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.69</td>
<td>0.72</td>
<td>0.72</td>
<td>0.77</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.61</td>
<td>0.73</td>
<td>0.83</td>
<td>0.84</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>74.44M</td>
<td>76.20M</td>
<td>74.53M</td>
<td>75.06M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>72.64M</td>
<td>75.66M</td>
<td>78.44M</td>
<td>79.76M</td>
</tr>
</tbody>
</table>

To track all earnings releases for AMERISAFE <a href="https://www.benzinga.com/quote/AMSF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMERISAFE: Q4 Earnings Insights

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.71 by 4.23 percent. The company reported quarterly sales of $80.12 million which beat the analyst consensus estimate of $75.15 million by 6.61 percent. This is a 0.45 percent increase over sales of $79.76 million the same period last year.

AMERISAFE Q4 2023 Adj EPS $0.74 Beats $0.71 Estimate, Sales $80.12M Beat $75.15M Estimate

ACVA

ALIT

ANSS

ATNI

BALY

BELFA

BELFB

BLCO

BRDG

BROS

BRSP

CAKE

CCAP

CCRN

CCSI

CENX

CHDN

CHRD

CNNE

COKE

CSTE

CSTM

DINO

DOCN

ECPG

ERII

ESEA

ETSY

EXAS

FIVN

GATO

GKOS

GLBE

GOOD

GRMN

GSHD

ICLR

INSG

IONS

JACK

JOBY

KALU

LANV

LCID

LIVN

LUNG

MATV

MGRC

MTLS

NDSN

NEXA

NGVT

NOVA

NVDA

NVRO

NYMT

OBDC

Earnings Scheduled For February 21, 2024

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-02-21. Here's what investors need to know before the announcement.
Analysts estimate that AMERISAFE will report an earnings per share (EPS) of $0.71. 
AMERISAFE bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.08, which was followed by a 2.77% drop in the share price the next day.
Here's a look at AMERISAFE's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.69</td>
<td>0.72</td>
<td>0.72</td>
<td>0.77</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.61</td>
<td>0.73</td>
<td>0.83</td>
<td>0.84</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.77%</td>
<td>-5.24%</td>
<td>3.97%</td>
<td>-2.07%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1708441327_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of AMERISAFE were trading at $50.25 as of February 19. Over the last 52-week period, shares are down 8.12%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/AMSF/earnings">To track all earnings releases for AMERISAFE visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For AMERISAFE

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) stock rose 2.38% to $82.5 during Wednesday's regular session. Trading volume for Arch Capital Group's stock is 801.6K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $30.1 billion. </li>
<li>American Coastal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) shares rose 2.32% to $11.89. As of 12:40 EST, this security is trading at a volume of 113.4K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $510.0 million. </li>
<li>AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) shares moved upwards by 2.09% to $50.25. As of 12:40 EST, this security is trading at a volume of 91.8K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $944.1 million. </li>
<li>Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>) stock increased by 1.76% to $14.97. The current volume of 22.1K shares is 0% of Hamilton Insurance Group's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $1.6 billion. </li>
<li>Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) stock increased by 1.38% to $385.0. The current volume of 118.4K shares is 0% of Everest Group's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $16.4 billion. </li>
<li>Brighthouse Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHFAP#NASDAQ">BHFAP</a>) stock rose 1.22% to $24.71. The current volume of 22.8K shares is 0% of Brighthouse Finl's average full-day volume over the last 100 days (last updated at 12:40 EST). </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) shares declined by 4.46% to $11.58 during Wednesday's regular session. As of 12:40 EST, this security is trading at a volume of 1.8K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at 566109838. </li>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) shares fell 4.35% to $1.32. Trading volume for Marpai's stock is 30.2K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.7 million. </li>
<li>Fanhua (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANH#NASDAQ">FANH</a>) shares fell 3.07% to $6.01. Trading volume for Fanhua's stock is 4.2K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $360.2 million. </li>
<li>Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) stock decreased by 2.86% to $8.18. As of 12:40 EST, this security is trading at a volume of 27.0K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $126.2 million. </li>
<li>Maiden Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHLD#NASDAQ">MHLD</a>) shares decreased by 2.83% to $1.72. Trading volume for this security as of 12:40 EST is 14.8K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $177.6 million. </li>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) shares decreased by 2.65% to $12.13. Trading volume for this security as of 12:40 EST is 15.0K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at 593002500. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ACGL

ACIC

BHFAP

FANH

MHLD

MRAI

ROOT

Insurance Stocks Moving In Wednesday's Intraday Session

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) stock rose 11.79% to $232.24 during Thursday's regular session. As of 13:40 EST, this security is trading at a volume of 804.6K shares, making up 119.9% of its average full-day volume over the last 100 days. The company's market cap stands at $23.0 billion. As per the news, the Q3 earnings report came out today. </li>
<li>Stewart Information Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STC#NYSE">STC</a>) stock moved upwards by 7.12% to $41.79. Trading volume for this security as of 13:40 EST is 179.7K, which is 107.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Global Indemnity Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBLI#NYSE">GBLI</a>) stock rose 5.03% to $36.76. As of 13:40 EST, this security is trading at a volume of 312 shares, making up 9.4% of its average full-day volume over the last 100 days. The company's market cap stands at $476.6 million. </li>
<li>Old Republic Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORI#NYSE">ORI</a>) shares rose 4.19% to $27.95. The current volume of 1.0 million shares is 65.2% of Old Republic Intl's average full-day volume over the last 100 days (last updated at 13:40 EST). The company's market cap stands at $7.6 billion. The company's, Q3 earnings came out today. </li>
<li>First American Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FAF#NYSE">FAF</a>) stock increased by 4.14% to $52.13. As of 13:40 EST, First American Financial's stock is trading at a volume of 712.0K, which is 143.1% of its average full-day volume over the last 100 days. The company's market cap stands at $5.1 billion. As per the press release, Q3 earnings came out today. </li>
<li>Fidelity National Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNF#NYSE">FNF</a>) shares increased by 3.15% to $38.55. Fidelity National Finl's stock is trading at a volume of 1.0 million shares as of 13:40 EST. This is 48.4% of its average full-day volume over the last 100 days. The company's market cap stands at $10.0 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kingstone Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) stock fell 5.33% to $1.7 during Thursday's regular session. Trading volume for this security as of 13:40 EST is 6.5K, which is 28.4% of its average full-day volume over the last 100 days. The company's market cap stands at $21.4 million. </li>
<li>Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) stock fell 4.51% to $4.76. As of 13:40 EST, Oscar Health's stock is trading at a volume of 648.7K, which is 42.6% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion. </li>
<li>Employers Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIG#NYSE">EIG</a>) shares fell 4.27% to $37.75. Employers Holdings's stock is trading at a volume of 65.1K shares as of 13:40 EST. This is 53.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li>Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) shares decreased by 4.01% to $1.44. As of 13:40 EST, this security is trading at a volume of 430 shares, making up 0.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.0 million. </li>
<li>AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) stock fell 3.76% to $50.47. AMERISAFE's stock is trading at a volume of 93.6K shares as of 13:40 EST. This is 114.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li>Citizens (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIA#NYSE">CIA</a>) stock decreased by 3.55% to $2.99. The current volume of 29.8K shares is 66.9% of Citizens's average full-day volume over the last 100 days (last updated at 13:40 EST). The company's market cap stands at $153.8 million. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GBLI

KINS

OSCR

RELI

Insurance Stocks Moving In Thursday's Intraday Session

AMERISAFE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>), a specialty provider of workers' compensation insurance focused on high-hazard industries, today announced that its Board of Directors had declared a special cash dividend of $3.50 per share.
The special cash dividend will be payable on December 15, 2023 to shareholders of record as of December 1, 2023. The Board of Directors also declared a regular quarterly dividend of $0.34 per share, payable on December 15, 2023 to shareholders of record as of December 1, 2023.
"We are pleased to announce this special dividend which reflects our underwriting expertise and discipline. Returning excess capital to shareholders via special dividends is a key component of AMERISAFE's capital management strategy," said G. Janelle Frost, President and Chief Executive Officer.
Over the past eleven years, the Company has declared $42.89 per share in dividends, comprising $9.64 in regular dividends and $33.25 in special dividends per share.
More information on the dividend and information on the company's third quarter earnings can be found in AMERISAFE's accompanying earnings release issued today.

AMERISAFE Declares Special Dividend Of $3.50 Per Share And Regular Quarterly Dividend Of $0.34 Per Share

Press Releases

AMERISAFE Announces 2024 First Quarter Earnings Release and Conference Call Schedule

AMERISAFE Announces 2024 First Quarter Results

AMERISAFE Announces 2024 Second Quarter Earnings Release and Conference Call Schedule

AMERISAFE Named to Ward's Property-Casualty Top Performers List for 16th Consecutive Year

AMERISAFE Announces 2024 Second Quarter Results

AM Best Affirms Credit Ratings of AMERISAFE, Inc. and Its Operating Subsidiaries

AMERISAFE Announces 2024 Third Quarter Earnings Release and Conference Call Schedule

AMERISAFE Announces 2024 Third Quarter Results

AMERISAFE Declares Special Dividend of $3.00 Per Share and Regular Quarterly Dividend

AMERISAFE Announces 2024 Fourth Quarter and Full Year Earnings Release and Conference Call Schedule

Comments

AMERISAFE

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga